335 related articles for article (PubMed ID: 18182819)
21. [Efficacy of tracrolimus 0.1% ointment in prurigo].
Lee HH; Sterry W; Worm M
J Dtsch Dermatol Ges; 2005 Sep; 3(9):690-4. PubMed ID: 16173976
[TBL] [Abstract][Full Text] [Related]
22. Topical tacrolimus--a novel treatment alternative for cutaneous chronic graft-versus-host disease.
Elad S; Or R; Resnick I; Shapira MY
Transpl Int; 2003 Sep; 16(9):665-70. PubMed ID: 12768230
[TBL] [Abstract][Full Text] [Related]
23. Three times weekly tacrolimus ointment reduces relapse in stabilized atopic dermatitis: a new paradigm for use.
Paller AS; Eichenfield LF; Kirsner RS; Shull T; Jaracz E; Simpson EL;
Pediatrics; 2008 Dec; 122(6):e1210-8. PubMed ID: 19015204
[TBL] [Abstract][Full Text] [Related]
24. Topical tacrolimus: an effective therapy for facial psoriasis.
Yamamoto T; Nishioka K
Eur J Dermatol; 2003; 13(5):471-3. PubMed ID: 14693492
[TBL] [Abstract][Full Text] [Related]
25. Tacrolimus ointment for the treatment of steroid-induced rosacea: a preliminary report.
Goldman D
J Am Acad Dermatol; 2001 Jun; 44(6):995-8. PubMed ID: 11369912
[TBL] [Abstract][Full Text] [Related]
26. Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment.
Wollenberg A; Reitamo S; Girolomoni G; Lahfa M; Ruzicka T; Healy E; Giannetti A; Bieber T; Vyas J; Deleuran M;
Allergy; 2008 Jul; 63(7):742-50. PubMed ID: 18592619
[TBL] [Abstract][Full Text] [Related]
27. Successful treatment of acrodermatitis continua suppurativa with topical tacrolimus 0.1% ointment.
Wilsmann-Theis D; Hagemann T; Dederer H; Wenzel J; Bieber T; Novak N
Br J Dermatol; 2004 Jun; 150(6):1194-7. PubMed ID: 15214910
[TBL] [Abstract][Full Text] [Related]
28. Plasma cell balanitis treated with tacrolimus 0.1%.
Moreno-Arias GA; Camps-Fresneda A; Llaberia C; Palou-Almerich J
Br J Dermatol; 2005 Dec; 153(6):1204-6. PubMed ID: 16307659
[TBL] [Abstract][Full Text] [Related]
29. Response of vitiligo to once- vs. twice-daily topical tacrolimus: a controlled prospective, randomized, observer-blinded trial.
Radakovic S; Breier-Maly J; Konschitzky R; Kittler H; Sator P; Hoenigsmann H; Tanew A
J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):951-3. PubMed ID: 19496898
[TBL] [Abstract][Full Text] [Related]
30. Successful treatment of plasma cell cheilitis with topical calcineurin inhibitors.
Choi JW; Choi M; Cho KH
J Dermatol; 2009 Dec; 36(12):669-71. PubMed ID: 19958456
[No Abstract] [Full Text] [Related]
31. Plasma cell cheilitis, successfully treated with topical 0.03% tacrolimus ointment.
Jin SP; Cho KH; Huh CH
J Dermatolog Treat; 2010 May; 21(3):130-2. PubMed ID: 19707925
[TBL] [Abstract][Full Text] [Related]
32. A comparison of treatment of oral lichen planus with topical tacrolimus and triamcinolone acetonide ointment.
Laeijendecker R; Tank B; Dekker SK; Neumann HA
Acta Derm Venereol; 2006; 86(3):227-9. PubMed ID: 16710580
[TBL] [Abstract][Full Text] [Related]
33. Superiority of tacrolimus 0.1% ointment compared with fluticasone 0.005% in adults with moderate to severe atopic dermatitis of the face: results from a randomized, double-blind trial.
Doss N; Reitamo S; Dubertret L; Fekete GL; Kamoun MR; Lahfa M; Ortonne JP
Br J Dermatol; 2009 Aug; 161(2):427-34. PubMed ID: 19416227
[TBL] [Abstract][Full Text] [Related]
34. Topical tacrolimus 0.03% ointment for intractable allergic conjunctivitis: an open-label pilot study.
Attas-Fox L; Barkana Y; Iskhakov V; Rayvich S; Gerber Y; Morad Y; Avni I; Zadok D
Curr Eye Res; 2008 Jul; 33(7):545-9. PubMed ID: 18600486
[TBL] [Abstract][Full Text] [Related]
35. The pharmacokinetics of tacrolimus after first and repeated dosing with 0.03% ointment in infants with atopic dermatitis.
Reitamo S; Mandelin J; Rubins A; Remitz A; Mäkelä M; Cirule K; Rubins S; Zigure S; Ho V; Dickinson J; Undre N
Int J Dermatol; 2009 Apr; 48(4):348-55. PubMed ID: 19335418
[TBL] [Abstract][Full Text] [Related]
36. Skin and systemic pharmacokinetics of tacrolimus following topical application of tacrolimus ointment in adults with moderate to severe atopic dermatitis.
Undre NA; Moloney FJ; Ahmadi S; Stevenson P; Murphy GM
Br J Dermatol; 2009 Mar; 160(3):665-9. PubMed ID: 19076975
[TBL] [Abstract][Full Text] [Related]
37. [Tacrolimus--a new therapeutic option for Hailey-Hailey-disease?].
Reuter J; Termeer C; Bruckner-Tuderman L
J Dtsch Dermatol Ges; 2005 Apr; 3(4):278-9. PubMed ID: 16370477
[TBL] [Abstract][Full Text] [Related]
38. A 4-year follow-up study of atopic dermatitis therapy with 0.1% tacrolimus ointment in children and adult patients.
Reitamo S; Rustin M; Harper J; Kalimo K; Rubins A; Cambazard F; Brenninkmeijer EE; Smith C; Berth-Jones J; Ruzicka T; Sharpe G; Taieb A;
Br J Dermatol; 2008 Sep; 159(4):942-51. PubMed ID: 18637898
[TBL] [Abstract][Full Text] [Related]
39. Vulvitis circumscripta plasmacellularis. A clinicopathologic entity?
Scurry J; Dennerstein G; Brenan J; Ostor A; Mason G; Dorevitch A
J Reprod Med; 1993 Jan; 38(1):14-8. PubMed ID: 8441125
[TBL] [Abstract][Full Text] [Related]
40. Impact of topical calcineurin inhibitors on quality of life in patients with atopic dermatitis.
Ingram JR; Martin JA; Finlay AY
Am J Clin Dermatol; 2009; 10(4):229-37. PubMed ID: 19489656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
